These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 25837283)
1. Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue. Rumbaugh G; Daws SE; Ozkan ED; Rojas CS; Hubbs CR; Aceti M; Kilgore M; Kudugunti S; Puthanveettil SV; Sweatt JD; Rusche J; Miller CA Neuropsychopharmacology; 2015 Sep; 40(10):2307-16. PubMed ID: 25837283 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Kilgore M; Miller CA; Fass DM; Hennig KM; Haggarty SJ; Sweatt JD; Rumbaugh G Neuropsychopharmacology; 2010 Mar; 35(4):870-80. PubMed ID: 20010553 [TBL] [Abstract][Full Text] [Related]
3. The Class I HDAC inhibitor RGFP963 enhances consolidation of cued fear extinction. Bowers ME; Xia B; Carreiro S; Ressler KJ Learn Mem; 2015 Apr; 22(4):225-31. PubMed ID: 25776040 [TBL] [Abstract][Full Text] [Related]
5. Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory. Zhao WN; Ghosh B; Tyler M; Lalonde J; Joseph NF; Kosaric N; Fass DM; Tsai LH; Mazitschek R; Haggarty SJ ACS Chem Neurosci; 2018 Sep; 9(9):2262-2273. PubMed ID: 29932631 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins. Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275 [TBL] [Abstract][Full Text] [Related]
7. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice. Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C J Alzheimers Dis; 2014; 41(4):1193-1205. PubMed ID: 24844691 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer's disease mouse model by regulating the expression of APP secretases. Zhang M; Wang W; Ye Q; Fu Y; Li X; Yang K; Gao F; Zhou A; Wei Y; Tian S; Li S; Wei F; Shi W; Li WD Alzheimers Res Ther; 2024 Jan; 16(1):15. PubMed ID: 38245771 [TBL] [Abstract][Full Text] [Related]
9. Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice. McClarty BM; Rodriguez G; Dong H Brain Res; 2024 Aug; 1837():148951. PubMed ID: 38642789 [TBL] [Abstract][Full Text] [Related]
10. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease. Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976 [TBL] [Abstract][Full Text] [Related]
11. Increased long-term potentiation at medial-perforant path-dentate granule cell synapses induced by selective inhibition of histone deacetylase 3 requires Fragile X mental retardation protein. Franklin AV; Rusche JR; McMahon LL Neurobiol Learn Mem; 2014 Oct; 114():193-7. PubMed ID: 24956240 [TBL] [Abstract][Full Text] [Related]
12. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease. Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models. Davis N; Taylor B; Abelleira-Hervas L; Karimian-Marnani N; Aleksynas R; Syed N; Di Giovanni S; Palmisano I; Sastre M FASEB J; 2024 May; 38(10):e23659. PubMed ID: 38733301 [TBL] [Abstract][Full Text] [Related]
15. An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. Kim MS; Akhtar MW; Adachi M; Mahgoub M; Bassel-Duby R; Kavalali ET; Olson EN; Monteggia LM J Neurosci; 2012 Aug; 32(32):10879-86. PubMed ID: 22875922 [TBL] [Abstract][Full Text] [Related]
16. SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. Hanson JE; La H; Plise E; Chen YH; Ding X; Hanania T; Sabath EV; Alexandrov V; Brunner D; Leahy E; Steiner P; Liu L; Scearce-Levie K; Zhou Q PLoS One; 2013; 8(7):e69964. PubMed ID: 23922875 [TBL] [Abstract][Full Text] [Related]
17. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease. Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830 [TBL] [Abstract][Full Text] [Related]
18. A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway. Han Y; Chen L; Liu J; Chen J; Wang C; Guo Y; Yu X; Zhang C; Chu H; Ma H Molecules; 2022 Jun; 27(13):. PubMed ID: 35807406 [TBL] [Abstract][Full Text] [Related]
19. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease. Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931 [TBL] [Abstract][Full Text] [Related]
20. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]